Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2079939-05-0
2. (-)-sirpiglenastat
3. Drp-104
4. Sirpiglenastat [usan]
5. 9gge6a0zmk
6. Sirpiglenastat [inn]
7. Sirpiglenastat [who-dd]
8. Sirpiglenastat (usan)
9. L-norleucine, N-acetyl-l-tryptophyl-6-diazo-5-oxo-, 1-methylethyl Ester
10. Propan-2-yl (2s)-2-((n-acetyl-l-tryptophyl)amino)-6-diazo-5-oxohexanoate
11. (s)-isopropyl 2-((s)-2-acetamido-3-(1h-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate
12. Refchem:183238
13. Drp104
14. Glutamine Antagonist Drp-104
15. Drp 104
16. Sirpiglenastat?
17. Orb1687484
18. Chembl4650367
19. Schembl20465436
20. Schembl29495819
21. Glxc-26739
22. Ex-a10433
23. Da-67601
24. Hy-132832
25. Cs-0204139
26. D12008
27. G18545
28. Isopropyl(s)-2-((s)-2-acetamido-3-(1h-indol-3-yl)-propanamido)-6-diazo-5-oxo-hexanoate
29. Propan-2-yl (2s)-2-[[(2s)-2-acetamido-3-(1h-indol-3-yl)propanoyl]amino]-6-diazo-5-oxohexanoate
| Molecular Weight | 441.5 g/mol |
|---|---|
| Molecular Formula | C22H27N5O5 |
| XLogP3 | 1.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 12 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 119 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 749 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 1 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
15
PharmaCompass offers a list of Sirpiglenastat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sirpiglenastat manufacturer or Sirpiglenastat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sirpiglenastat manufacturer or Sirpiglenastat supplier.
A Sirpiglenastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sirpiglenastat, including repackagers and relabelers. The FDA regulates Sirpiglenastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sirpiglenastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sirpiglenastat supplier is an individual or a company that provides Sirpiglenastat active pharmaceutical ingredient (API) or Sirpiglenastat finished formulations upon request. The Sirpiglenastat suppliers may include Sirpiglenastat API manufacturers, exporters, distributors and traders.
Sirpiglenastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sirpiglenastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sirpiglenastat GMP manufacturer or Sirpiglenastat GMP API supplier for your needs.
A Sirpiglenastat CoA (Certificate of Analysis) is a formal document that attests to Sirpiglenastat's compliance with Sirpiglenastat specifications and serves as a tool for batch-level quality control.
Sirpiglenastat CoA mostly includes findings from lab analyses of a specific batch. For each Sirpiglenastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sirpiglenastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Sirpiglenastat EP), Sirpiglenastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sirpiglenastat USP).
